Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11357)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2019 (publication date) through Nov 2, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Ramachandra Pai RP, Kangath RV. Bilateral gangrene of fingers in a patient on empagliflozin: First case report. World J Diabetes 2019; 10(2): 133-136 [PMID: 30788049 DOI: 10.4239/wjd.v10.i2.133] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Ramachandra Pai RP, Kangath RV. Bilateral gangrene of fingers in a patient on empagliflozin: First case report. World J Diabetes 2019; 10(2): 133-136 [PMID: 30788049 DOI: 10.4239/wjd.v10.i2.133] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v10/i2/133.htm |
| Number | Citing Articles |
| 1 |
Jyoti Yadav, Farogh Ahsan, Prabhudatta Panda, Tarique Mahmood, Vaseem Ahamad Ansari, Arshiya Shamim. Empagliflozin-A Sodium Glucose Co-transporter-2 Inhibitor: Overview of
its Chemistry, Pharmacology, and Toxicology. Current Diabetes Reviews 2024; 20(10) doi: 10.2174/0115733998271026231127051545
|
| 2 |
Mario Antunes, Antonio Cabrera de León, Damiano Pizzol, Amir Hussein Abubacar Seni, Mike Trott, Anne Marie Carrie, Petre-Cristian Ilie, Nicola Veronese, Lee Smith. Empagliflozin Use and Fournier’s Gangrene: Case Report and Systematic Literature Review. Surgeries 2021; 2(2): 174 doi: 10.3390/surgeries2020018
|
| 3 |
|
| 4 |
Mortaza F. Hassanabad, Zahra F.H. Abad. Are SGLT2 inhibitors joining the mainstream therapy for diabetes type 2?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(3): 1893 doi: 10.1016/j.dsx.2019.04.041
|